Jonathan Montagu (@JDMontagu) profile picture

Jonathan Montagu

@JDMontagu
 Cambridge, MA
hotspotthera.com
Joined December 2012
  • Tweets80
  • Following213
  • Followers296
Jonathan Montagu retweeted
Vanessa King (@VanessaE_King) profile picture
Vanessa King@VanessaE_King12 Sep 2019
Congrats, @NavitorPharma team! Patients await better treatments and hope that NV-5138 continues on its efficacious clinical path!
Navitor Pharma (@NavitorPharma) profile pictureNavitor Pharma@NavitorPharma12 Sep 2019
Proud to announce initial P1 results for NV-5138! Data show the rapid antidepressant effects and biomarker impact of our direct activator of mTORC1, and lay the groundwork for further development in #depression. Read more here: bit.ly/2kbNgKM
1
1
5
Jonathan Montagu retweeted
Samantha Truex (@SamTruex) profile picture
Samantha Truex@SamTruex23 Aug 2019
Congrats to @hotspotthera on this visionary move! – at Cambridge, MA
HotSpot Therapeutics (@hotspotthera) profile pictureHotSpot Therapeutics@hotspotthera23 Aug 2019
We’re excited to announce the acquisition of Macroceutics, a provider of DEL screening technologies. This technology enhances the capabilities of our Spotfinder™ platform to accelerate hit expansion and optimization efforts for #allosteric drug discovery. hotspotthera.com/press_relea…

HotSpot Therapeutics Announces Acquisition of Macroceutics, Inc. - HotSpot Therapeutics

BOSTON, Mass. (August 23, 2019)— HotSpot Therapeutics, Inc, a biotechnology company pioneering the discovery of nature’s regulatory sites to advance...

hotspotthera.com
1
3
1
11
Congrats to Daphne and her team!
Rosana Kapeller (@KapellerRosana) profile pictureRosana Kapeller@KapellerRosana16 Apr 2019
With $150M and a new NASH discovery deal with Gilead, AI star Daphne Koller has set out to change the drug R&D world – Endpoints News endpts.com/with-150m-and-a-n…
With $150M and a new NASH discovery deal with Gilead, AI star Daphne Koller has set out to change...

With $150M and a new NASH discovery deal with Gilead, AI star Daphne Koller has set out to change...

Daphne Koller spent the last year quietly putting together one of the biggest plays in biopharma AI. And backed by some of the deepest pockets in biotech, she’s now marking a key turning point for...

endpoints.news
4
Artificial intelligence is over hyped at the moment but ignoring AI would be a big mistake. Here's a perspective on how machine learning is going to impact drug design and chemistry: hotspotthera.com/cats-and-th…

Cats and the future of machine learning in drug discovery - HotSpot Therapeutics

The predictions around the impact of artificial intelligence (AI) have been broad reaching but it’s clear that not everyone is...

hotspotthera.com
3
Exposing the Real North Korea Through Secret Photography anothermag.com/art-photograp… via @AnOtherMagazine
Exposing North Korea Through Secret Photography

Exposing North Korea Through Secret Photography

Armed with a hidden shutter-release and travelling on a stranger's passport, photographer Nathalie Daoust explains the measures she took to capture the mysterious underbelly of North Korean society

anothermag.com
1
20 of Naty's photos from North Korea in Germany's largest magazine spon.de/aeLw5 via @SPIEGELONLINE
1
1
Jonathan Montagu retweeted
Jeb Keiper (@JebKeiper) profile picture
Jeb Keiper
@JebKeiper16 Apr 2016
If you couldn't make #ILC2016 read #NimbusTx Ph1b abstract here: bit.ly/1W6nv7P
Image from Jeb Keiper (@JebKeiper)
5
5
Incredible day for the Nimbus team. Congrats all round! bit.ly/1S2INh3
1
1
1
Jonathan Montagu retweeted
Michael Koeris (@mkoeris) profile picture
Michael Koeris
@mkoeris4 Apr 2016
When it rains it pours @atlasventure! Congrats @LifeSciVC @JDMontagu et al. at Nimbus! xitter.cf/lifescivc/status/71696… – at Cambridge, MA
Bruce Booth (@LifeSciVC) profile pictureBruce Booth
@LifeSciVC4 Apr 2016
Nimbus Delivers Its Apollo Mission: A $1.2B Gilead Partnership. lifescivc.com/2016/04/nimbus…
Nimbus Delivers Its Apollo Mission: A $1.2B Gilead Partnership - LifeSciVC

Nimbus Delivers Its Apollo Mission: A $1.2B Gilead Partnership - LifeSciVC

Today Gilead announced the acquisition of Nimbus’ lead program targeting NASH and related metabolic disorders for $400M upfront and up to another $800M in development and regulatory milestones...

lifescivc.com
1
4
"Scientists are pigment makers," he said. "Drug developers make the art." fiercebiotech.com/story/biot…
Jonathan Montagu retweeted
Bruce Booth (@LifeSciVC) profile picture
Bruce Booth
@LifeSciVC21 Apr 2015
Nimbus' allosteric ACC inhibitor is in clinic! Initially for NASH/HCC, but broad metabolic potenital. nimbustx.com/news-events/pre…
1
7
9
"10 Essential Berlin Books" good read - for those interested in the authentic Berlin iheartberlin.de/2014/11/19/1…
1
1
REVIEWS! ★★★★★ @WhatsOnStage | ★★★★★ @SortedMagazine | ★★★★ @TheStage | ★★★★ @British_Theatre | ★★★★ @westendwilma | ★★★★ @digitalspy
1
7
3
Jonathan Montagu retweeted
Matthew Herper (@matthewherper) profile picture
Matthew Herper
@matthewherper6 Aug 2014
$MDCO's oritavancin has been approved. I've been following this drug for most of my career.
5
3
2
Jonathan Montagu retweeted
Andrew Lancel (@AndrewLancel) profile picture
Andrew Lancel@AndrewLancel6 Aug 2014
As a #beatle fan..when the Beatles fan... @EpsteinThePlay britishbeatlesfanclub.co.uk/…
2
1
RT were you one of the presenters? @juliacowens: #BioArbor session on virtual cos tonight w/ 3 virtual co CEOs.
1
Jonathan Montagu retweeted
Paul D. Rennert (@PDRennert) profile picture
Paul D. Rennert@PDRennert4 Jun 2014
Replying to @LifeSciVC
@LifeSciVC @JDMontagu excellent perspective and really reenforces lessons I learned my first time goin 'round the virtual wheel. good stuff
1
2
Jonathan Montagu retweeted
Bruce Booth (@LifeSciVC) profile picture
Bruce Booth
@LifeSciVC4 Jun 2014
Biotech’s Virtual Reality - new "From The Trenches" post from @JDMontagu lifescivc.com/2014/06/biotec…
2
10
5
Another plug for late risers: $ICPT, Government Scientists Spar Over Negative Safety of Liver Drug, Emails Say —> thestreet.com/story/12714549…
5
12
6
A Phase I Clinical Trial of Systemically Delivered NEMO Binding Domain Peptide... - reviewed in @F1000 f1000.com/prime/smartsearch/…
Load more